Azathioprine Shared Care AgreementAzathioprine Shared Care Agreement • December 10th, 2019
Patient’s NHS Number:Name: Date of Birth: Date TreatmentStarted: Copy of information given to patient Copy of agreement to general practitioner Name of Initiating Nurse Specialist / Doctor: Consultant:Speciality: RHEUMATOLOGY Email: trauma.ortho@nhs.net
AZATHIOPRINE SHARED CARE AGREEMENT (SCA)Azathioprine Shared Care Agreement • March 18th, 2015
SPECIALIST RESPONSIBILITIES 1. Assess patient, confirm diagnosis and discuss benefits and risks of treatment with the patient.2. Perform pre-treatment assessments and on-going monitoring as detailed on page 2.3. Initiate, titrate and stabilise the patient on treatment with oral azathioprine. Prescribers should familiarise themselves with the drug indication, dose, administration, contra-indications, cautions, side-effects, interactions and preparation by referring to the current version of the Summary of Product Characteristics (http://www.medicines.org.uk/emc/default.aspx) or the BNF/BNF for Children (http://www.medicinescomplete.com/mc/index.htm).4. Provide appropriate written information on azathioprine to the patient.5. Discuss proposed SCA with the patient and explain that their GP may or may not wish to participate. The patient has the choice to continue receiving treatment solely from the specialist if they wish.6. Send a letter to the patient’s GP to request participation in th
